Article Information
PubMed
Published By
History
- Received November 18, 2017
- Revision received September 8, 2018
- Accepted September 16, 2018
- Published online October 12, 2018.
Copyright & Usage
Copyright © 2018 Brimblecombe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Katherine R. Brimblecombe1,
- Sarah Threlfell1,2,
- Daniel Dautan3,4,
- Polina Kosillo1,*,
- Juan Mena-Segovia3,4 and
- Stephanie J. Cragg1,2
- 1Department of Physiology, Anatomy and Genetics, Sherrington Building, Oxford, UK
- 2Oxford Parkinson’s Disease Centre, University of Oxford, Oxford OX1 3PT, UK
- 3MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford, UK
- 4Center for Molecular and Behavioral Neuroscience, Rutgers University, Newark, NJ
- Address correspondence to Stephanie J. Cragg, Department of Physiology, Anatomy and Genetics, University of Oxford, OX1 3PT, UK. E-mail: stephanie.cragg{at}dpag.ox.ac.uk.
Author contributions
Author Contributions: All authors designed research; K.R.B., P.K., S.T., and D.D. performed research; and K.R.B., J.M.-S., and S.J.C. wrote the paper.
Disclosures
The authors declare no competing financial interests.
Funded by MRC (grant MR/K013866/1) and Parkinson’s UK (J-1403; G-1305).
Funding
Medical Research Council (MRC)
MR/K013866/1Parkinson's UK
J-1403; G-1305Clarendon Fund
Other Version
- You are viewing the most recent version of this article.
- previous version (October 12, 2018).
Online Impact
Article usage
In this issue
Targeted Activation of Cholinergic Interneurons Accounts for the Modulation of Dopamine by Striatal Nicotinic Receptors
